The Prevalence of Peptic Ulcer not Related to Helicobacter pylori or Non‐Steroidal Anti‐Inflammatory Drug Use is Negligible in Southern Europe
- 24 May 2004
- journal article
- Published by Wiley in Helicobacter
- Vol. 9 (3) , 249-254
Abstract
Background and Aim. Helicobacter pylori is the major cause of peptic ulcer disease, but the proportion of H. pylori-negative peptic ulcers seems to be increasing in developed countries. We investigated the frequency of H. pylori-negative peptic ulcer without intake of nonsteroidal anti-inflammatory drugs (NSAIDs) in a Mediterranean European country. Materials and Methods. We prospectively collected consecutive patients with an endoscopically verified active peptic ulcer over 6 months from different areas of Spain. Helicobacter pylori infection was assessed by rapid urease test and histologic examination (corpus and antral biopsies). A 13C-urea breath test was performed if H. pylori was not detected with the invasive test. Patients were considered H. pylori-negative if all three tests were negative. NSAID use was determined by structured data collection. Results. Of 754 consecutive peptic ulcer patients, 16 (2.1%) were H. pylori-negative and had not used NSAIDs before the diagnosis. Of the 472 patients who had duodenal ulcers, 95.7% (n = 452) were H. pylori-positive and only 1.69% (n = 8) were negative for both H. pylori infection and NSAID use; 193 patients had benign gastric ulcers and 87% (n = 168) of them were infected by H. pylori (p < .001 vs. duodenal ulcers). NSAID intake was more frequent in gastric ulcer patients (52.8%) than in duodenal ulcer patients (25.4%; p < .001). Consequently, the frequency of H. pylori-negative gastric ulcer in patients not using NSAID was 4.1% (n = 8). Conclusion. Peptic ulcer disease is still highly associated with H. pylori infection in southern Europe, and only 1.6% of all duodenal ulcers and 4.1% of all gastric ulcers were not associated with either H. pylori infection or NSAID use.Keywords
This publication has 17 references indexed in Scilit:
- Peptic-ulcer diseaseThe Lancet, 2002
- Is non-Helicobacter pylori, non-NSAID peptic ulcer a common cause of upper GI bleeding? A prospective study of 977 patientsGastrointestinal Endoscopy, 2001
- Prevalence and Risk Factors of Helicobacter pylori-negative Peptic UlcerJournal of Clinical Gastroenterology, 2000
- Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID usersAlimentary Pharmacology & Therapeutics, 1999
- Low prevalence of Helicobacter pylori in an Australian duodenal ulcer population: NSAIDitis or the effect often years of H. pylori treatment?Australian and New Zealand Journal of Medicine, 1998
- Large U.S. clinical trials report a high proportion of H. Pylori negative duodenal ulcers at study entry as well as a high recurrence rate after cure of the infection: Have we all been wrong?Gastroenterology, 1998
- What Is the Role of Helicobacter pylori in Peptic Ulcer and Gastric Cancer Outside the Big Cities?Journal of Clinical Gastroenterology, 1998
- Helicobacter pylori infection in a healthy population in SpainEuropean Journal of Gastroenterology & Hepatology, 1996
- A study of the pathogenesis of Helicobacter pylori negative chronic duodenal ulceration.Gut, 1993
- UNIDENTIFIED CURVED BACILLI IN THE STOMACH OF PATIENTS WITH GASTRITIS AND PEPTIC ULCERATIONThe Lancet, 1984